Clinical Trial Supply and Logistics Market Study 2018: Impressively growing Opportunities Catalent Pharma Solutions, Almac Group, Movianto, Patheon

CoherentMarketInsights.com Publish a New Market Research Report On –“ Clinical Trial Supply and Logistics Market 2019 Global Analysis By Key Players – Catalent Pharma Solutions, Inc., Almac Group, Movianto, Patheon, Inc., PCI Pharma Distribution, Sharp Packaging Distribution, PAREXEL International Corporation, Marken, KLIFO A/S, and Biocair.”. 

The Global Clinical Trial Supply and Logistics Market, By Service (Manufacturing, Packaging and Labeling, and Distribution), By End User (Pharmaceutical, Medical Devices, and Biologics) was valued at US$ 14.95 Bn in 2017 and is projected to exhibit a CAGR of 7.1% over the forecast period (2018 - 2026), as highlighted in a new report published by Coherent Market Insights.

Various clinical trial supply and logistics management companies are indulged in offering smart tools to solve problems in delivering trial-related supplies to multiple locations, identify opportunities, reduce costs, and enhance future trials. Clinical supply management provides other supplies such as disposable products, refrigerators, centrifuges, and diagnostic, testing, and imaging medical equipment apart from the investigational medicinal products. These factors are expected to create lucrative opportunities for the manufacturers to develop drugs or technologically advanced medical devices with ease.

Access PDF Template Copy of this Report at:
https://www.coherentmarketinsights.com/insight/request-pdf/1798

The shift in geographical distribution of clinical trials by various biopharmaceutical companies from regions such as Central and Eastern Europe, Asia Pacific, Latin America, and Middle East for cost-effective and quick patient recruitment is expected drive growth of the clinical trial supply and logistics market. Furthermore, Asia Pacific region provides greater economic benefits to biopharmaceutical companies, as government in China and Singapore allocate funds to promote biomedical research in the region. Also, Asia Pacific possess various kind of different diseases, which helps in conducting clinical trials with more significant results and outcome. In April 2018, Zuellig Pharma Holdings Pte. Ltd. entered into a distribution agreement with Taiho Pharma, Singapore for their product, TS-ONE OD Tablet, which is the first anticancer agent in the form of disintegrating tablet for the patients who are facing difficulty in swallowing capsules or whose water intake is restricted.

The global clinical trial supply and logistics market is expected to expand at a CAGR of 7.1% during the forecast period (2018 – 2026), owing to increasing number of clinical trials, increasing complexities, and rising number of biologics and biosimilar drugs in trials

On the basis of service, distribution segment is expected to show maximum traction during the forecast period, owing to the rising outsourcing storage and distribution facility

On the basis of end user, pharmaceutical segment holds largest market share, owing to increasing research activities for oncology therapeutic application. However, steady decrease in R&D pipeline for pharmaceutical drugs has been observed and it is being substituted by biological drugs, which is expected to impact the segment over the next eight years.

Get Discount & Customization of this Report Here
https://www.coherentmarketinsights.com/insight/request-customization/1798

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com

This release was published on openPR.